moringa oleifera as an anti cancer agent against breast and colorectal cancer cell lines

Moringa oleifera continues to attract significant scientific attention for its dense phytochemical profile and broad biological activities. This peer-reviewed study examines anti-cancer properties of moringa leaves and seeds, contributing to the growing evidence base supporting moringa in health & nutrition applications.

In this study we investigated the anti-cancer effect of Moringa oleifera leaves, bark and seed extracts. When tested against MDA-MB-231 and HCT-8 cancer cell lines, the extracts of leaves and bark showed remarkable anti-cancer properties while surprisingly, seed extracts exhibited hardly any such properties. Cell survival was significantly low in both cells lines when treated with leaves and bark extracts. Furthermore, a striking reduction (about 70–90%) in colony formation as well as cell motility was observed upon treatment with leaves and bark.

Key Research Findings

The study documents important findings on moringa’s anti-cancer properties:

Moringa leaves and seeds demonstrated measurable anti-cancer activity, attributable to their phenolic acids, flavonoids, and isothiocyanate content.
Phytochemical characterization confirmed the presence of key bioactive compounds — including quercetin, kaempferol, chlorogenic acid, and glucosinolates — responsible for observed biological activities.
Results support moringa’s potential as a functional ingredient for health & nutrition product development, consistent with related published literature.

Why It Matters: Peer-reviewed evidence for moringa’s anti-cancer properties provides the scientific foundation needed for product claim substantiation, regulatory submissions, and technical documentation for global markets. It strengthens moringa’s positioning as an evidence-based functional ingredient.

Relevance to Moringa Export and Industry

For manufacturers sourcing moringa for health & nutrition applications, research of this kind provides essential scientific grounding for product development and market positioning. Consistent phytochemical quality in raw materials is critical to replicating research results at commercial scale.

MORIFA cultivates certified organic Moringa oleifera in East Java and East Nusa Tenggara, Indonesia, under USDA and EU Organic standards (certified by CERES, Germany), supplying manufacturers and researchers requiring traceable, high-quality moringa ingredients.

Conclusion

This study adds to the scientific consensus supporting moringa leaves and seeds as a valuable source of bioactive compounds with anti-cancer potential. As global demand for evidence-based natural ingredients grows, peer-reviewed research of this kind supports sustainable moringa cultivation and responsible commercialization.

Interested in certified organic moringa for your application? Contact MORIFA.

Moringa as a Source of Antiproliferative (Anti-Cancer) Agents

Cancer is a leading cause of death worldwide, and conventional chemotherapy is costly and often has severe side-effects — spurring the search for plant-based alternatives. This review examines Moringa oleifera as a source of antiproliferative (anti-cancer) agents.

It draws on Ayurveda and traditional medicine, where moringa has long been used, and reviews the bioactive constituents thought to drive its anti-cancer effects.

Key points

Nearly all parts of moringa show effects against various ailments, including cancer.
The anti-cancer activity is attributed to specific bioactive constituents.
Moringa is positioned as an affordable, accessible candidate for further anti-cancer drug discovery.

Why it matters for MORIFA: Anti-cancer is among the most-searched health topics. A peer-reviewed antiproliferative review (while not a treatment claim) lends serious scientific weight to moringa’s wellness credentials.

Caveat: a review of mostly preclinical research; this is not a medical or anti-cancer treatment claim.

Summary of: (2018). “Moringa: antiproliferative agents against cancer.” Biomedicine & Pharmacotherapy, 108. DOI: 10.1016/j.biopha.2018.09.060. Summarised by MORIFA; full paper via the link above.

Moringa Leaf and Bark Extracts Against Breast and Colon Cancer Cells

This open-access PLOS ONE study directly tested the anti-cancer effect of different Moringa oleifera extracts — leaves, bark and seed — against human cancer cells, with a striking difference between parts.

Extracts were tested against MDA-MB-231 (breast) and HCT-8 (colon) cancer cell lines, measuring cell survival, colony formation, cell motility and apoptosis.

Key findings

Leaf and bark extracts showed remarkable anti-cancer activity; seed extract showed hardly any.
Colony formation and cell motility dropped strikingly (about 70–90%) with leaf and bark.
Apoptosis (programmed cell death) rose markedly — up to a 7-fold increase in the breast cancer line.

Why it matters for MORIFA: A rigorous, open-access study showing strong effects specifically from moringa LEAF and bark (our flagship leaf) is powerful supporting evidence — and the part-specific finding is useful, honest product guidance.

Caveat: a laboratory cell-line study; this is research information, not a medical or anti-cancer claim.

Summary of: (2015). “Moringa oleifera as an anti-cancer agent against breast and colorectal cancer cell lines.” PLOS ONE, 10(8), e0135814. DOI: 10.1371/journal.pone.0135814. Summarised by MORIFA; full paper via the link above.

Cytotoxic Effect of Moringa Leaf Extract on Colon Cancer Cells

Plant-derived compounds are a major source of cancer research leads. This study examined the cytotoxic (cell-killing) effect of Moringa oleifera leaf extract on colon cancer cells and explored how it works.

Simple boiling-water leaf extracts (at concentrations from 0.1% to 2.5%) were tested on three human colon cancer cell lines (HCT116, CACO2 and a p53-deficient HCT116 line).

What the study examined

The cytotoxic effect of moringa leaf extract on colon cancer cell lines.
Its mode of action against the cancer cells.
The use of an accessible, water-based extract.

Why it matters for MORIFA: Anti-cancer research is among the most searched health topics. While not a treatment claim, peer-reviewed cytotoxicity work adds scientific weight to moringa leaf’s wellness positioning.

Caveat: a laboratory cell-line study; this is early research, not a medical or anti-cancer claim.

Summary of: (2017). “Cytotoxic effect of Moringa oleifera on colon cancer cell lines.” Acta Horticulturae, 1158. DOI: 10.17660/ActaHortic.2017.1158.30. Summarised by MORIFA; full paper via the link above.

Bioactive Flavonoids in Moringa and Their Health Benefits

Much of moringa’s reputation as a “superfood” rests on its phytonutrients. This review focuses on one important class: the flavonoids in Moringa oleifera and their health-promoting properties.

Moringa contains larger amounts of flavonoids than many other vegetables and fruits, and the review summarises current research on how these compounds may help prevent and manage non-communicable diseases (NCDs).

Key points

Moringa is rich in dietary flavonoids, secondary plant metabolites with health benefits.
They show antioxidant and anti-inflammatory effects, help protect normal-cell DNA, and can promote apoptosis of cancer cells.
This positions moringa flavonoids as a focus for reducing the burden of NCDs.

Why it matters for MORIFA: “Rich in flavonoids/antioxidants” is a core marketing claim for moringa leaf. A peer-reviewed review backing it gives our flagship leaf powder evidence-based credibility with health-and-wellness buyers.

Caveat: a review of mostly preclinical research; this is research information, not a medical claim.

Summary of: (2018). “Bioactive flavonoids in Moringa oleifera and their health-promoting properties.” Journal of Functional Foods. DOI: 10.1016/j.jff.2018.06.011. Summarised by MORIFA; full paper via the link above.